In the UK, several GLP-1 receptor agonists are licensed by the Medicines and Healthcare products Regulatory Agency (MHRA), each with specific indications: semaglutide (Ozempic for type 2 diabetes, Wegovy for weight management), dulaglutide (Trulicity for type 2 diabetes), and liraglutide (Victoza for type 2 diabetes, Saxenda for weight management)
All content is provided for informational purposes only and does not constitute medical, clinical, or therapeutic advice
From this perspective, peptides such as relaxin-3 may be more relevant to behavioral subtypes of metabolic disease than to weight loss per se
Is ferroptosis caused exclusively by an excessive lipid peroxides accumulation due to GSH depletion and oxidative damage, or also by cysteine insufficiency itself
J Cosmet Dermatol 20:964970
Tanzilli G, Truscelli G, Arrivi A, et al